Diagnostics company Molbio files DRHP with Sebi for an IPO

Molbio Diagnostics, a Goa-based POC diagnostics company, filed its DRHP to raise Rs 200 crore via fresh issue and 1.25 crore shares through OFS. Its patented ‘Truenat’ PCR platform enables rapid decentralized testing. FY25 revenue stood at Rs 1,020 crore, PAT Rs 138.5 crore. Promoters include Sriram family and Exxora Trading.

More To Explore

2 top stock recommendations from Vinay Rajani

Indian equity markets are experiencing a cautious phase, consolidating within a defined range as fresh buying momentum remains elusive. Technical analysts suggest the broader trend

June 29, 2026

Advertiser Disclosure

Great-investor.com helps users across the globe to find out The latest news, Guides, and Info about finance and investments. Furthermore, our content and research teams do not participate in any advertising planning nor are they permitted access to advertising campaign data.

Disclaimer

It is our organization’s primary mission to provide reviews, commentary, and analysis that are unbiased and objective. While great-investor.com has some data verified by industry participants, it can vary from time to time. Operating as an online business, this site may be compensated through third party advertisers. Our receipt of such compensation shall not be construed as an endorsement or recommendation by great-investor.com, nor shall it bias our reviews, analysis, and opinions. Please see our General Disclaimers for more information.

The information on this website does not constitute investment advice or a recommendation or a solicitation to engage in any investment activity. This website and its content are not intended for residents of the UAE, US, Canada, Australia, UK, Russia, North Korea, China, Japan, Hong Kong, Singapore and Iran.

Top10 International FZ LLE | 17th Floor, Creative Tower | 4422 | Fujairah | TRN: 100608946800003